You just read:

Ipsen Announces Health Canada Approval of DYSPORT THERAPEUTIC™ (abobotulinumtoxinA) for the Treatment of Patients with Cervical Dystonia and Adult Upper Limb Spasticity

News provided by

Ipsen Biopharmaceuticals Canada Inc.

Mar 14, 2017, 08:00 ET